ข่าวประชาสัมพันธ์ rheumatoid arthritis+Caroline Wozniacki

Tennis Champion Caroline Wozniacki and UCB Launch Advantage Hers Campaign for Women with Chronic Inflammatory Diseases

- Grand Slam winner Caroline Wozniacki is the highest-ranking female athlete known to have been diagnosed with rheumatoid arthritis whilst still playing professional tennis - Advantage Hers will equip and empower women around the world living with chronic inflammatory diseases, such as rheumatoid arthritis, to take more active roles in shared decision-making about their care UCB, a global biopharmaceutical company, has partnered with world-renowned tennis champion Caroline Wozniacki to launch

Menarini Asia-Pacific Enters into an Exclusive Licensing Agreement with Astellas to Commercialize Smyraf(R) in Taiwan and select South-East Asian markets

Menarini Asia-Pacific has entered into a long-term exclusive licensing partnership with Astellas Pharma Inc. (Astellas) for the development,...

Zydus Launches World’s First Biosimilar of Adalimumab

Access to this therapy will impact 12 million people suffering from auto immune disorders like rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, and Ankylosing Spondylitis in India After more than a decade-long wait, the...

Coherus Announces Initiation Of Phase 3 Trial Of CHS-0214 (Investigational Etanercept Biosimilar) In Chronic Plaque Psoriasis (RaPsOdy)

Company Advances Development as Part of Collaboration with Baxter International's Biopharmaceutical Business Coherus BioSciences, Inc. announced the start of its...

Coherus Announces Initiation Of Phase 3 Trial Of CHS-0214 (Investigational Etanercept Biosimilar) In Rheumatoid Arthritis

Coherus Advances Development as Part of Collaboration with Daiichi Sankyo and Baxter Coherus BioSciences, Inc. announced the start of its Phase 3 trial of CHS-0214, an...

Yok Chinese Restaurant of the Emerald Hot... “Marinated shredded chicken with jelly fish served cold” @ Yok Chinese Restaurant — Yok Chinese Restaurant of the Emerald Hotel would like to invite you t...

Turkish Airlines becomes the Official Airline Partner of World’s number one woman tennis tournament

Turkish Airlines added a new asset to its sports sponsorship portfolio by becoming the official airline partner of the TEB BNP Paribas WTA Championships, the season-ending finale of the WTA (Women’s...

ออริเฟลม เปิดตัว พรีเซ็นเตอร์คนใหม่ “แคโรไลน์ วอซเนียคกี้” นักเทนนิสหญิงมือ 1 ของโลก ตัวแทนความหวัง มุ่งมั่น อันแข็งแกร่ง แบบฉบับสาวยุคใหม่

ออริเฟลม (Oriflame) ผลิตภัณฑ์ความงามจากธรรมชาติสัญชาติสวีเดน ที่เปิดโอกาสให้คนถึง 3.6 ล้านคนทั่วโลกได้มีธุรกิจแบบอิสระ และสร้างยอดขายที่สูงถึง 1.5 พันล้าน...

Number one Tennis player, Caroline Wozniacki was chosen to become the new face of Turkish Airlines Business Class...

Within the framework of international brand recognition, focusing on specific studies, Turkish Airlines has made a deal with the world number one female tennis player, Caroline...

Data Published Today Reveal That Novel Oral Therapy Fostamatinib Demonstrates Positive Response in Rheumatoid Arthritis Patients

- Phase II Study Published in the New England Journal of Medicine AstraZeneca's (LSE: AZN) new oral syk inhibitor, fostamatinib (R788), recently in-licensed from Rigel...

Sport & fashion heading for the next U.S. Open final – Caroline Wozniacki to wear new adidas by Stella McCartney fall/winter 2010 tennis dress –

This week the world-class tennis talent Caroline Wozniacki is wearing her new U.S. Open tennis dress at Flushing Meadows, New York. The Danish top five...

Rheumatoid Arthritis Patients Want Pain-Free Days at Christmas

- Results From a Survey Conducted by UCB Assessing the Lifestyles of Women With Rheumatoid Arthritis in Seven Major Industrialized Countries - A third of women living with rheumatoid arthritis say their disease impacts their enjoyment of...

Asian Countries Cannot Afford To Ignore the Cost of Rheumatoid Arthritis

- Early Diagnosis and Treatment for Patients with Rheumatoid Arthritis Urgently Needed to Relieve Social, Economic and Personal Disease Burden - - New Initiative Launched to Highlight the Need to Reassess Treatment Approaches in...

ฮูไมร่า (HUMIRA)(R) (adalimumab) ของแอ๊บบอตได้รับการยกย่องจากรางวัล กาเลน ไพรซ์ว่า เป็นนวัตกรรมในการรักษาผู้ป่วย

พริกซ์ กาเลียน จากสหรัฐอเมริกา ยกย่องให้ฮูไมร่าเป็นสินค้าเทคโนโลยีชีวภาพที่ดีที่สุด แอ๊บบอต (NYSE: ABT) ผู้นำในการรักษาโรคเกี่ยวกับภูมิคุ้มกันอัตโนมัติ ได้รับรางวัลกาเลน ไพรซ์ ปี 2007 ...

Abbott's HUMIRA(R) (adalimumab) Honored With Prestigious Galen Prize for Innovation in Patient Care

Prix Galien USA Names HUMIRA Best Biotechnology Product Abbott (NYSE: ABT), a leader in the treatment of autoimmune diseases, has received the 2007 Galen Prize for Best Biotechnology Product for HUMIRA...

Actemra: Roche's Novel Rheumatoid Arthritis Drug Shows Substantial Benefits for Patients in OPTION Study

New Data Supports IL-6 Receptor Inhibition as a Key Component in Controlling Inflammation From RA Roche today announced significant results from 'OPTION'(1), the first rheumatoid arthritis...

Latest Data Show MabThera(R) Provides Significant and Sustained Relief From Signs and Symptoms of Rheumatoid Arthritis

Patients Experience Consistent Safety Profile With Subsequent Courses of Therapy New data presented at the EULAR meeting (European League Against Rheumatism) demonstrate that...